FDA Drug Repurposing Uncovers Modulators of Dopamine D2 Receptor Localization via Disruption of the NCS-1 Interaction. [PDF]
Muñoz-Reyes D +13 more
europepmc +1 more source
The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry. [PDF]
Bramlage P +9 more
europepmc +1 more source
Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril. [PDF]
Bönner G +8 more
europepmc +1 more source
First Description of Sprue-Like Enteropathy due to Azilsartan: A Case Report. [PDF]
Stoeckli L +4 more
europepmc +1 more source
Activity of GPCR-targeted drugs influenced by human gut microbiota metabolism. [PDF]
Wu Q +8 more
europepmc +1 more source
A nonhydrolyzable candesartan cilexetil analog reveals synergistic activation as a tractable mechanism for TMEM175 modulation. [PDF]
Li K +8 more
europepmc +1 more source
Identification of Endogenous Hypercortisolism and the Effect of Mifepristone Treatment in Patients With Difficult-to-Manage Diabetes: A Case Series. [PDF]
Lucci CP, McCoy G.
europepmc +1 more source
Effectiveness of thiazide diuretics in patients with hypertension: a systematic review and meta-analysis. [PDF]
Ashraf T +14 more
europepmc +1 more source
Impact of the national centralized volume-based procurement policy on antihypertensive drug procurement, price, and volume in Guangxi: an interrupted time series analysis of procurement data. [PDF]
Liang S +5 more
europepmc +1 more source

